Taiwanese Journal of Obstetrics & Gynecology最新文献

{"title":"Low-level mosaic trisomy 14 at amniocentesis in a pregnancy associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, positive non-invasive prenatal testing for trisomy 14, perinatal progressive decrease of the trisomy 14 cell line and a favorable fetal outcome","authors":"Chih-Ping Chen ,&nbsp;Fang-Tzu Wu ,&nbsp;Shu-Yuan Chang ,&nbsp;Peih-Shan Wu ,&nbsp;Yen-Ting Pan ,&nbsp;Meng-Shan Lee ,&nbsp;Chien-Ling Chiu ,&nbsp;Wayseen Wang","doi":"10.1016/j.tjog.2024.07.006","DOIUrl":"10.1016/j.tjog.2024.07.006","url":null,"abstract":"<div><h3>Objective</h3><p>We present low-level mosaic trisomy 14 at amniocentesis.</p></div><div><h3>Case report</h3><p>A 37-year-old, gravida 2, para 1, woman underwent amniocentesis at 18 weeks of gestation because of advanced maternal age. This pregnancy was conceived by <em>in vitro</em> fertilization and embryo transfer (IVF-ET). Amniocentesis revealed a karyotype of 47,XX,+14 [4]/46,XX [27], consistent with 12.9% mosaicism for trisomy 14. Simultaneous array comparative genomic hybridization (aCGH) analysis on the DNA extracted from uncultured amniocytes revealed the result of arr (1–22, X) × 2 with no genomic imbalance. Prenatal ultrasound findings were unremarkable. She was referred for genetic counseling at 21 weeks of gestation and was offered expanded non-invasive prenatal testing (NIPT) which was positive for trisomy 14. At 24 weeks of gestation, she underwent repeat amniocentesis which revealed a karyotype of 47,XX,+14 [2]/46,XX [26], consistent with 7% mosaicism for trisomy 14. The parental karyotypes were normal. Simultaneous aCGH analysis on the DNA extracted from uncultured amniocytes revealed no genomic imbalance. Polymorphic marker analysis excluded uniparental disomy (UPD) 14. Interphase fluorescence <em>in situ</em> hybridization (FISH) analysis on 104 uncultured amniocytes detected no trisomy 14 cell. At 35 weeks of gestation, a 2315-g phenotypically normal baby was delivered. The umbilical cord and placenta had the karyotype of 46, XX (40/40 cells). aCGH analysis on the DNA extracted from peripheral blood and buccal mucosal cells at the age of three months revealed no genomic imbalance. The neonate was normal in phenotype and development during postnatal follow-ups.</p></div><div><h3>Conclusions</h3><p>Low-level mosaic trisomy 14 at amniocentesis can be associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, perinatal progressive decrease of the trisomy 14 cell line and a favorable fetal outcome.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 5","pages":"Pages 755-758"},"PeriodicalIF":2.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001888/pdfft?md5=70718a6574d09ffd36a85fd5df0d08a8&pid=1-s2.0-S1028455924001888-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142163971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Balanced reciprocal translocation mosaicism of mosaic 46,XY,t(4;10) (q12;p12.32)/46,XY at amniocentesis in a pregnancy with a favorable outcome and no prominent perinatal decrease of the balanced translocation cell line","authors":"Chih-Ping Chen","doi":"10.1016/j.tjog.2024.05.015","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.05.015","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 575-577"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001426/pdfft?md5=edff7874b0a51f8d30e38a3395b6d317&pid=1-s2.0-S1028455924001426-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A common problem between gynecology, obstetrics, and reproductive medicine: Cesarean section scar defect","authors":"Ping-Lun Lin ,&nbsp;Jung-Hsiu Hou ,&nbsp;Chi-Huang Chen","doi":"10.1016/j.tjog.2024.03.018","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.03.018","url":null,"abstract":"<div><p>Approximately 60% of patients undergoing Cesarean sections may develop Cesarean Scar Defect (CSD), presenting a significant clinical challenge amidst the increasing Cesarean section rates. This condition, marked by a notch in the anterior uterine wall, has evolved as a notable topic in gynecological research. The multifactorial origins of CSD can be broadly classified into labor-related factors, patients' physical conditions, and surgical quality. However, conflicting influences of certain factors across studies make it challenging to determine effective preventive strategies. Additionally, CSD manifests with diverse symptoms, such as abnormal uterine bleeding, dysmenorrhea, chronic pelvic pain, dyspareunia, secondary infertility, and Cesarean scar pregnancy. Some symptoms are often attributed to other diagnoses, leading to delayed treatment. The quandary of when and how to manage CSD also adds to the complexity. Despite the development of various therapies, clear indications and optimal methods for specific conditions remain elusive. This longstanding challenge has troubled clinicians in both identifying and addressing this iatrogenic disease.</p><p>Recent studies have yielded some compelling consensuses on various aspects of CSD. This review aims to consolidate the current literature on every facet of CSD. We hope to raise awareness among clinicians about this clinical problem, encouraging more relevant research to unveil the complete picture of CSD.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 459-470"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001207/pdfft?md5=b06870a5d3875ff9fb910dd22e8a6b32&pid=1-s2.0-S1028455924001207-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Relevant obstetrics outcomes and gynecology-related clinical data on Andersen-Tawil syndrome","authors":"Adela Bazbaz,&nbsp;Armando Totomoch-Serra,&nbsp;Manlio F. Márquez-Murillo","doi":"10.1016/j.tjog.2024.04.013","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.04.013","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 590-591"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001499/pdfft?md5=8b70fea4bff06b7a73f274a32c6aa886&pid=1-s2.0-S1028455924001499-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between hypertensive disorders of pregnancy and gestational diabetes and risk of atopic dermatitis in childhood: A systematic review and meta-analysis","authors":"Li Pan ,&nbsp;Qiuhe Song ,&nbsp;Fei Xiong ,&nbsp;Fan Hong ,&nbsp;Kun Zhu","doi":"10.1016/j.tjog.2024.04.006","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.04.006","url":null,"abstract":"<div><p>The purpose of this review was to examine if maternal hypertensive disorders of pregnancy (HDP) and gestational diabetes mellitus (GDM) result in an increased risk of atopic dermatitis or eczema (AD-E) in childhood. We searched the databases of PubMed, Embase, CENTRAL, Web of Science, and Scopus for cohort or case–control studies up to 25th June 2023. Random-effects meta-analysis was done to generate the odds ratio (OR) of the association between HDP/GDM and AD-E. Eight studies were included. Meta-analysis of five studies showed that GDM in the mother was associated with an increased risk of AD-E in the offspring (OR: 1.35 95% CI: 1.13, 1.61 I² = 61%). Pooled analysis of four studies demonstrated no association between HDP and risk of AD-E in the offspring (OR: 1.03 95% CI: 0.99, 1.08 I² = 0%). The results did not change on sensitivity analysis and subgroup analysis based on study type, method of AD-E diagnosis, and sample size. This meta-analysis suggests that GDM may significantly increase the risk of AD-E in childhood, however, HDP does not seem to impact the risk of AD-E. Evidence is limited by the small number of studies and high interstudy heterogeneity. Further studies are needed to improve the quality of evidence.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 479-485"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001220/pdfft?md5=eb06efd5130e1930328fe66eb586eabd&pid=1-s2.0-S1028455924001220-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dienogest treatment in women with endometriosis: A retrospective cohort study in Taiwan","authors":"Yi-Chieh Chen ,&nbsp;Chia-Huang Chang ,&nbsp;Ya-Lun Tsai ,&nbsp;Ming-Song Tsai ,&nbsp;Li-Ching Chen","doi":"10.1016/j.tjog.2024.04.009","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.04.009","url":null,"abstract":"<div><h3>Objective</h3><p>To assess the treatment efficacy of dienogest specifically in the Taiwanese population with endometriosis.</p></div><div><h3>Materials and Methods</h3><p>Eighty-eight patients diagnosed with endometriosis receiving at least 3 months of dienogest 2 mg once daily, from January 2018 to June 2022, were enrolled. They were divided into two groups: surgery group and non-surgery group. The assessment of pain improvement was based on visual analog scale (VAS) scores (0–100 mm) recorded at 0, 3, 6, and 12 months following the initiation of dienogest. Serum CA-125 value and ovarian endometrioma size were analyzed at 0 and 6 months.</p></div><div><h3>Results</h3><p>A total of 65 patients with endometriosis presented painful symptoms. In the surgery group (N = 28), the initial VAS score was 47.5 mm, which significantly declined to 9.6 mm at 3 months (p &lt; 0.01), then to 7.5 mm, 2.9 mm, and 2.1 mm at 6, 9, and 12 months, respectively. In the non-surgery group (N = 37), the initial VAS score was 65.7 mm, which significantly declined to 13.2 mm at 3 months (p &lt; 0.01) and 4.9 mm at 6 months (p &lt; 0.05), remained low at 0.3 mm at both 9 and 12 months. Endometrioma size (N = 33) exhibited a significant 35% decrease from 38.2 mm to 24.8 mm after 6 months treatment (p &lt; 0.01). Serum CA-125 levels showed significant improvement from 86.5 to 30.2 U/ml (p &lt; 0.01) at 6 months.</p></div><div><h3>Conclusion</h3><p>This retrospective cohort study proved that dienogest is effective in reducing endometriosis-associated pain and endometrioma size in Taiwanese population.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 532-535"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S102845592400130X/pdfft?md5=38b65bc20f7b9796ed96a263489e7dba&pid=1-s2.0-S102845592400130X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prenatal diagnosis of familial 3p26.3p25.3 deletion in a pregnancy associated with a favorable fetal outcome and asymptomatic carrier parent and family members in three generations","authors":"Chih-Ping Chen ,&nbsp;Fang-Tzu Wu ,&nbsp;Yen-Ting Pan ,&nbsp;Peih-Shan Wu ,&nbsp;Meng-Shan Lee ,&nbsp;Wayseen Wang","doi":"10.1016/j.tjog.2024.05.010","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.05.010","url":null,"abstract":"<div><h3>Objective</h3><p>We present prenatal diagnosis of familial 3p26.3p25.3 deletion in a pregnancy associated with a favorable fetal outcome and asymptomatic carrier parent and family members in three generations.</p></div><div><h3>Case Report</h3><p>A 35-year-old, gravida 2, para 1, woman underwent amniocentesis at 17 weeks of gestation because of advanced maternal age and the carrier of distal 3p deletion. She was phenotypically normal, and there was no family history of congenital anomalies. Amniocentesis revealed a karyotype of 46,XY,del(3)(p26.1). Repeat amniocentesis at 21 weeks of gestation revealed a karyotype of 46,XY,del(3)(p25.3). Simultaneous array comparative genomic hybridization (aCGH) analysis on the DNA extracted from uncultured amniocytes showed the result of arr 3p26.3p25.3 (117,735–8,709,972) × 1.0 [GRCh37 (hg19)] with an 8.59-Mb deletion of 3p26.3p25.3 encompassing 14 OMIM genes of <em>CHL1</em>, <em>CNTN6</em>, <em>CNTN4</em>, <em>IL5RA</em>, <em>TRNT1</em>, <em>CRBN</em>, <em>SETMAR</em>, <em>SUMF1</em>, <em>ITPR1</em>, <em>BHLHE40</em>, <em>ARL8B</em>, <em>GRM7</em>, <em>LMCD1</em> and <em>SSUH2</em>. Cytogenetic analysis of parental bloods revealed a karyotype of 46,XX,del (3) (p25.3) in the mother and 46,XY in the father. The woman's 69-year-old mother and her 2-year-old elder son carried the same aberrant chromosome of 3p25.3→p26.3 deletion by conventional cytogenetic analysis but manifested no phenotypic abnormality. aCGH analysis of the peripheral bloods showed that the woman's mother and her elder son had the same 8.59-Mb deletion of 3p26.3p25.3. The woman was advised to continue the pregnancy. At 39 weeks of gestation, a 3040-g healthy male baby was delivered. When follow-up at age 2½ years, the neonate was normal in development and showed no apparent phenotypic abnormality.</p></div><div><h3>Conclusion</h3><p>Distal 3p deletion of 3p26.3p25.3 involving the OMIM genes from <em>CHL1</em> to <em>SSUH2</em> can be associated with no apparent phenotypic abnormality.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 561-564"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001372/pdfft?md5=a086a94126f8f475fb4b82fdb8f45167&pid=1-s2.0-S1028455924001372-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of early removal of urinary catheter on recovery after vaginal surgery: A systematic review and meta-analysis","authors":"Yueh-Yin Fang ,&nbsp;Pei-Fan Mu ,&nbsp;Lok-Hi Chow","doi":"10.1016/j.tjog.2024.05.005","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.05.005","url":null,"abstract":"<div><p>Prolonged retention of urinary catheters (UC) after vaginal surgery is a common practice aimed at preventing postoperative urinary retention and enhancing the success rate of surgery. However, this approach also increases the chance of urinary tract infection (UTI), prolongs hospital stay (LOS), and delays recovery. Balancing these considerations, we investigated the effect of the timing of UC removal. We conducted a comprehensive literature search using four databases to identify all randomized controlled trials (RCTs) involving patients who underwent transvaginal surgery and had UC removal within 7 days postsurgery. This systematic review was conducted by two reviewers independently following the PRISMA guideline. This study investigated the timing of catheter removal in relation to the incidence of urinary retention, UTI, and LOS. A total of 8 RCT studies, involving 952 patients were included in the meta-analysis. Six studies revealed no significant difference in the urinary retention rate between early catheter removal group (24 h) and delayed removal group (&gt;48 h, P = 0.21), but exhibited a significantly reduced UTI rate (P &lt; 0.001) in 4 studies. In 2 studies, no significant difference in urinary retention rate between the earlier removal (3 h) and removal at 24 h (P = 0.09), and also UTI rate (P = 0.57). Overall, 5 studies revealed that early catheter removal significantly shortened the LOS by an average of 1–3 days (P ≤ 0.001). Early removal of UC can considerably reduce the rate of UTI and shorten the LOS. Moreover, it has potential benefits in terms of improving the quality of patient care and reducing medical costs.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 451-458"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001190/pdfft?md5=7dc19e55b85641936126aceb01b28f93&pid=1-s2.0-S1028455924001190-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dual-staining with P16 and Ki67 in the triaging of ASC-US and the LSIL group beneficial or added financial burden, still a diagnostic dilemma","authors":"Pratibha Singh,&nbsp;Meenakshi Gothwal,&nbsp;Garima Yadav","doi":"10.1016/j.tjog.2024.05.019","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.05.019","url":null,"abstract":"","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Page 593"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001517/pdfft?md5=10839dbd3078eac42b995879d78f98dc&pid=1-s2.0-S1028455924001517-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lower limb lymphedema after surgical staging for endometrial cancer: Current insights and future directions","authors":"Giuseppe Cucinella ,&nbsp;Mariano Catello Di Donna ,&nbsp;Jvan Casarin ,&nbsp;Gabriella Schivardi ,&nbsp;Francesco Multinu ,&nbsp;Letizia Borsellino ,&nbsp;Natalina Buono ,&nbsp;Giulia Zaccaria ,&nbsp;Antonino Abbate ,&nbsp;Antonio Simone Laganà ,&nbsp;Vito Chiantera","doi":"10.1016/j.tjog.2024.04.008","DOIUrl":"https://doi.org/10.1016/j.tjog.2024.04.008","url":null,"abstract":"<div><p>Lower extremity lymphedema (LEL) is a common complication following surgical staging of endometrial cancer. LEL is a chronic condition associated with significant impact on patient morbidity and quality of life (QoL). This review aimed to report the current evidence in the literature on secondary LEL after surgical staging for endometrial cancer, focusing on the incidence based on different approaches to lymph node staging, diagnosis, risk factors, and the impact on QoL. Due to the absence of a standardized agreement regarding the methodology for evaluating LEL, the documented frequency of occurrence fluctuates across different studies, ranging from 0% to 50%. Systematic pelvic lymphadenectomy appears to be the primary determinant associated with the emergence of LEL, whereas the implementation of sentinel lymph node biopsy has notably diminished the occurrence of this lymphatic complication after endometrial cancer staging. LEL is strongly associated with decreased QoL, lower limb function, and negative body image, and has a detrimental impact on cancer-related distress reported by survivors. Standardization of lymphedema assessment is needed, along with cross-cultural adaptation of subjective outcome measures for self-reported LEL. The advent of sentinel lymph node mapping represents the ideal approach for accurate nodal assessment with less short- and long-term morbidity. Further research is needed to definitively assess the prevalence and risk factors of LEL and to identify strategies to improve limb function and QoL in cancer survivors with this chronic condition.</p></div>","PeriodicalId":49449,"journal":{"name":"Taiwanese Journal of Obstetrics & Gynecology","volume":"63 4","pages":"Pages 500-505"},"PeriodicalIF":2.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1028455924001256/pdfft?md5=ae618a6c7a6f64aaccc3519b312d7f44&pid=1-s2.0-S1028455924001256-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}